These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Eringa EC; Bakker W; Smulders YM; Serné EH; Yudkin JS; Stehouwer CD Microcirculation; 2007; 14(4-5):389-402. PubMed ID: 17613810 [TBL] [Abstract][Full Text] [Related]
4. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Chalmers L; Kaskel FJ; Bamgbola O Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Sarafidis PA; Ruilope LM Am J Nephrol; 2006; 26(3):232-44. PubMed ID: 16733348 [TBL] [Abstract][Full Text] [Related]
6. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470 [TBL] [Abstract][Full Text] [Related]
7. Vascular dysfunction in obesity and insulin resistance. Frisbee JC Microcirculation; 2007; 14(4-5):269-71. PubMed ID: 17613800 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Singer G; Granger DN Microcirculation; 2007; 14(4-5):375-87. PubMed ID: 17613809 [TBL] [Abstract][Full Text] [Related]
9. Podocyte lesions in patients with obesity-related glomerulopathy. Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996 [TBL] [Abstract][Full Text] [Related]
11. Renal consequences of obesity. Naumnik B; Myśliwiec M Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624 [TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766 [TBL] [Abstract][Full Text] [Related]
13. [Overweight and obesity--risk factors in the development and progression of renal disease]. Sebeková K; Klassen A; Bahner U; Heidland A Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263 [TBL] [Abstract][Full Text] [Related]
14. [Obesity, inflammation and insulin resistance: which role for adipokines]. Antuna-Puente B; Feve B; Fellahi S; Bastard JP Therapie; 2007; 62(4):285-92. PubMed ID: 17983554 [TBL] [Abstract][Full Text] [Related]
15. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Sarafidis PA Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384 [TBL] [Abstract][Full Text] [Related]
16. Adipokines: the missing link between insulin resistance and obesity. Antuna-Puente B; Feve B; Fellahi S; Bastard JP Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861 [TBL] [Abstract][Full Text] [Related]
17. [The importance of overweight and obesity for the development and progression of renal diseases]. Klassen A; Bahner U; Sebekova K; Heidland A Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412 [No Abstract] [Full Text] [Related]